Benmoxin

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Benmoxin
Benmoxin skeletal.svg
Systematic (IUPAC) name
N-(1-phenylethyl)benzohydrazide
Clinical data
Legal status Prescription only
Routes Oral
Identifiers
CAS number 7654-03-7 N
ATC code None
PubChem CID 71671
ChemSpider 64728 YesY
UNII XC9FY2SGBG YesY
ChEMBL CHEMBL1877495 N
Chemical data
Formula C15H16N2O 
Mol. mass 240.30 g/mol
 N (what is this?)  (verify)

Benmoxin (trade names Neuralex, Nerusil), also known as mebamoxine, is an irreversible and nonselective monoamine oxidase inhibitor (MAOI) of the hydrazine class.[1][2] It was synthesized in 1967 and was subsequently used as an antidepressant in Europe, but is now no longer marketed.[1][2]

See also[edit]

References[edit]

  1. ^ a b Ganellin, C. R.; Triggle, David J. (1996). Dictionary of Pharmacological Agents, Volumes 1-2. Chapman & Hall. p. 229. ISBN 0-9630096-0-5. 
  2. ^ a b Swiss Pharmaceutical Society (2000). Index Nominum 2000: International Drug Directory (Book with CD-ROM). Boca Raton: Medpharm Scientific Publishers. ISBN 3-88763-075-0.